Study questions FDA's shorter drug approval times

WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the Journal of the American Medical Association found.

via Reuters: Health News Read More Here..